|Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study|
CMM Prado, JR Lieffers, LJ McCargar, T Reiman, MB Sawyer, L Martin, ...
The lancet oncology 9 (7), 629-635, 2008
|A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care|
M Mourtzakis, CMM Prado, JR Lieffers, T Reiman, LJ McCargar, ...
Applied Physiology, Nutrition, and Metabolism 33 (5), 997-1006, 2008
|Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment|
CMM Prado, VE Baracos, LJ McCargar, T Reiman, M Mourtzakis, ...
Clinical Cancer Research 15 (8), 2920-2926, 2009
|Muscle wasting is associated with mortality in patients with cirrhosis|
AJ Montano–Loza, J Meza–Junco, CMM Prado, JR Lieffers, VE Baracos, ...
Clinical Gastroenterology and Hepatology 10 (2), 166-173. e1, 2012
|Body composition as an independent determinant of 5-fluorouracil–based chemotherapy toxicity|
CMM Prado, VE Baracos, LJ McCargar, M Mourtzakis, KE Mulder, ...
Clinical Cancer Research 13 (11), 3264-3268, 2007
|Sarcopenic obesity: a critical appraisal of the current evidence|
CMM Prado, JCK Wells, SR Smith, BCM Stephan, M Siervo
Clinical Nutrition 31 (5), 583-601, 2012
|Lean Tissue Imaging A New Era for Nutritional Assessment and Intervention|
CMM Prado, SB Heymsfield
Journal of Parenteral and Enteral Nutrition 38 (8), 940-953, 2014
|A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands|
JR Lieffers, M Mourtzakis, KD Hall, LJ McCargar, CMM Prado, ...
The American journal of clinical nutrition 89 (4), 1173-1179, 2009
|The emerging role of computerized tomography in assessing cancer cachexia|
CMM Prado, LA Birdsell, VE Baracos
Current opinion in supportive and palliative care 3 (4), 269-275, 2009
|Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results|
L Thoresen, G Frykholm, S Lydersen, H Ulveland, V Baracos, CMM Prado, ...
Clinical Nutrition 32 (1), 65-72, 2013
|Sarcopenia as a Prognostic Index of Nutritional Status in Concurrent Cirrhosis and Hepatocellular Carcinoma|
J Meza-Junco, AJ Montano-Loza, VE Baracos, CMM Prado, VG Bain, ...
Journal of clinical gastroenterology 47 (10), 861-870, 2013
|Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation|
AJ Montano‐Loza, J Meza‐Junco, VE Baracos, CMM Prado, M Ma, ...
Liver Transplantation 20 (6), 640-648, 2014
|Calorie for calorie, dietary fat restriction results in more body fat loss than carbohydrate restriction in people with obesity|
KD Hall, T Bemis, R Brychta, KY Chen, A Courville, EJ Crayner, ...
Cell metabolism 22 (3), 427-436, 2015
|Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?|
CM Prado, MB Sawyer, S Ghosh, JR Lieffers, N Esfandiari, S Antoun, ...
The American journal of clinical nutrition 98 (4), 1012-1019, 2013
|Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis|
AJ Montano‐Loza, P Angulo, J Meza‐Junco, CMM Prado, MB Sawyer, ...
Journal of cachexia, sarcopenia and muscle 7 (2), 126-135, 2016
|Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later|
AM Ryan, DG Power, L Daly, SJ Cushen, ĒN Bhuachalla, CM Prado
Proceedings of the Nutrition Society 75 (2), 199-211, 2016
|Osteosarcopenic obesity: the role of bone, muscle, and fat on health|
MJ Ormsbee, CM Prado, JZ Ilich, S Purcell, M Siervo, A Folsom, L Panton
Journal of cachexia, sarcopenia and muscle 5 (3), 183-192, 2014
|An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity|
CMM Prado, ISF Lima, VE Baracos, RR Bies, LJ McCargar, T Reiman, ...
Cancer chemotherapy and pharmacology 67 (1), 93-101, 2011
|Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity|
CMM Prado, S Antoun, MB Sawyer, VE Baracos
Current Opinion in Clinical Nutrition & Metabolic Care 14 (3), 250-254, 2011
|Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma|
CMM Prado, T Bekaii-Saab, LA Doyle, S Shrestha, S Ghosh, VE Baracos, ...
British journal of cancer 106 (10), 1583, 2012